Literature DB >> 8179186

Assessment of various techniques for the quantitative extraction of lysophospholipids from myocardial tissues.

N A Shaikh1.   

Abstract

Lipid extraction methods were evaluated for their effectiveness in extracting lysophosphatidylcholines and lysophosphatidylethanolamines from tissues and for subsequent recoveries during purification of crude extracts. The acid-butanol technique, although effective in complete extraction, resulted in partial hydrolysis (2-10%) of phospholipids containing 1-alk-1'-enyl-2-acylglycerophospholipids (plasmalogens) to produce artifactual lysophospholipids. This problem was avoided using a neutral butanol extraction or Bligh and Dyer techniques, but these resulted in only partial recoveries (60-72 and 75-80%, respectively) of these lipids. Tissue extracted with neutral chloroform-methanol mixtures provided virtually complete extraction (97-100%), but subsequent losses (up to 15%) occurred during purification of crude extracts with Folch synthetic upper phases. These losses could be circumvented by purification of the crude extract on Sephadex G-25 column. As an alternative, the Folch extraction technique was modified to achieve complete recoveries of lysophospholipids. This involved extraction of the tissue with a chloroform-methanol-saline biphasic system. After removal of the lower lipid phase, the upper phase containing residual tissue was reextracted twice more with Folch lower phase and once with lower phase containing HCl. This last extract was neutralized with NH3 vapor before pooling with the preceding extracts. This method (i) circumvents plasmalogenic hydrolysis, (ii) avoids use of time-consuming column chromatography, (iii) eliminates the losses of lipids during purification, and (iv) allows highly reproducible quantitative analyses of all lipid fractions including lysophospholipids and nonesterified fatty acids from myocardial tissue.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8179186     DOI: 10.1006/abio.1994.1047

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  7 in total

1.  Fatty-acyl chain profiles of cellular phosphoinositides.

Authors:  Alexis Traynor-Kaplan; Martin Kruse; Eamonn J Dickson; Gucan Dai; Oscar Vivas; Haijie Yu; Dale Whittington; Bertil Hille
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2017-02-09       Impact factor: 4.698

2.  Inhibition of neutral sphingomyelinase-2 perturbs brain sphingolipid balance and spatial memory in mice.

Authors:  Nino Tabatadze; Alena Savonenko; Hongjun Song; Veera Venkata Ratnam Bandaru; Michael Chu; Norman J Haughey
Journal:  J Neurosci Res       Date:  2010-10       Impact factor: 4.164

3.  Lipid profiling of rat peritoneal surface layers by online normal- and reversed-phase 2D LC QToF-MS.

Authors:  Honggang Nie; Ranran Liu; Youyou Yang; Yu Bai; Yafeng Guan; Daqing Qian; Tao Wang; Huwei Liu
Journal:  J Lipid Res       Date:  2010-06-06       Impact factor: 5.922

4.  Increase by lysophosphatidylcholines of smooth muscle Ca2+ sensitivity in alpha-toxin-permeabilized small mesenteric artery from the rat.

Authors:  P E Jensen; J Ohanian; B Stausbøl-Grøn; N H Buus; C Aalkjaer
Journal:  Br J Pharmacol       Date:  1996-03       Impact factor: 8.739

5.  Tumor necrosis factor-alpha-induced neutral sphingomyelinase-2 modulates synaptic plasticity by controlling the membrane insertion of NMDA receptors.

Authors:  David Wheeler; Edward Knapp; Veera V R Bandaru; Yue Wang; David Knorr; Christophe Poirier; Mark P Mattson; Jonathan D Geiger; Norman J Haughey
Journal:  J Neurochem       Date:  2009-03-14       Impact factor: 5.372

6.  Phospholipids in milk fat: composition, biological and technological significance, and analytical strategies.

Authors:  Giovanna Contarini; Milena Povolo
Journal:  Int J Mol Sci       Date:  2013-01-29       Impact factor: 5.923

7.  Cambinol, a novel inhibitor of neutral sphingomyelinase 2 shows neuroprotective properties.

Authors:  Mariana Figuera-Losada; Marigo Stathis; Joelle M Dorskind; Ajit G Thomas; Veera Venkata Ratnam Bandaru; Seung-Wan Yoo; Nicholas J Westwood; Graeme W Rogers; Justin C McArthur; Norman J Haughey; Barbara S Slusher; Camilo Rojas
Journal:  PLoS One       Date:  2015-05-26       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.